What is Relay Therapeutics, Inc.'s financing cash flow?

Relay Therapeutics, Inc. (RLAY) reported financing cash flow of $138.78M in Q1 2026.

What is the long-term trend for Relay Therapeutics, Inc.'s financing cash flow?

Over 3 years (2021 to 2024), Relay Therapeutics, Inc.'s financing cash flow has grown at a -11.4% compound annual growth rate (CAGR), from $388.09M to $270.15M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Relay Therapeutics, Inc. RLAY Financing Cash Flow

Financing Cash Flow at other companies

CelcuityCELC

$34K-99.4%

Revolution Medicines, Inc.RVMD

$238.74M+27,216%

Ligand PharmaceuticalsLGND

-$14.13M-198%

Cogent Biosciences, Inc.COGT

$52.54M+110%

Tango TherapeuticsTNGX

$79.85M+3,992,200%

Spyre Therapeutics, Inc.SYRE

$12.26M+9,704%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.46B+300%

Enterprise value$3.29B+304%

P/S324.1×+212×

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s financing cash flow?: Relay Therapeutics, Inc. (RLAY) reported financing cash flow of $138.78M in Q1 2026.
What is the long-term trend for Relay Therapeutics, Inc.'s financing cash flow?: Over 3 years (2021 to 2024), Relay Therapeutics, Inc.'s financing cash flow has grown at a -11.4% compound annual growth rate (CAGR), from $388.09M to $270.15M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.